Go Pro
→ They told you not to miss this one (From Thor Metals) (Ad)tc pixel Free OVID Stock Alerts

Ovid Therapeutics (OVID) Institutional Ownership

Ovid Therapeutics logo
$2.43 -0.09 (-3.57%)
Closing price 07/13/2026 04:00 PM Eastern
Extended Trading
$2.40 -0.03 (-1.40%)
As of 04:09 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Ovid Therapeutics (NASDAQ:OVID)

Current
Institutional Ownership
Percentage
72.24%
Number of
Institutional Buyers
(last 12 months)
40
Total
Institutional Inflows
(last 12 months)
$102.92M
Number of
Institutional Sellers
(last 12 months)
18
Total
Institutional Outflows
(last 12 months)
$11.87M
Get OVID Insider Trade Alerts

Want to know when executives and insiders are buying or selling Ovid Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

OVID Institutional Buying and Selling by Quarter

Ovid Therapeutics Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
7/8/2026 Assenagon Asset Management S.A.17,544$47K0.0%-92.3%0.009%
5/19/2026Bank of America Corp DE290,432$645K0.0%+49.0%0.220%
5/19/2026Janus Henderson Group PLC10,714,000$23.73M0.0%N/A8.124%
5/19/2026Ally Bridge Group NY LLC2,818,459$6.26M5.1%+57.9%2.137%
5/18/2026ADAR1 Capital Management LLC4,544,113$10.09M0.6%+6.0%3.446%
5/15/2026OMERS ADMINISTRATION Corp100,100$222K0.0%-20.1%0.076%
5/15/2026Affinity Asset Advisors LLC10,636,318$23.61M1.2%+48.8%8.065%
5/14/2026Renaissance Technologies LLC1,104,300$2.45M0.0%-25.6%0.837%
5/14/2026Sei Investments Co.328,924$730K0.0%N/A0.249%
5/14/2026Walleye Capital LLC443,362$984K0.0%-16.3%0.336%
5/14/2026State of Wyoming22,171$49K0.0%N/A0.017%
4/27/2026Simplify Asset Management Inc.130,813$290K0.0%N/A0.099%
4/20/2026 Assenagon Asset Management S.A.227,742$506K0.0%-63.1%0.173%
4/17/2026Total Clarity Wealth Management Inc.20,975$47K0.0%-26.7%0.016%
4/17/2026Sovereign Financial Group Inc.30,000$67K0.0%+200.0%0.023%
2/19/2026Invesco Ltd.33,308$54K0.0%N/A0.047%
2/18/2026ADAR1 Capital Management LLC4,285,000$6.99M0.5%+33,256.7%6.017%
2/18/2026Ikarian Capital LLC247,558$404K0.0%-77.4%0.348%
2/18/2026Quadrature Capital Ltd87,874$143K0.0%+217.2%0.123%
2/18/2026Millennium Management LLC1,339,465$2.18M0.0%+35.8%1.881%
2/18/2026Balyasny Asset Management L.P.325,000$530K0.0%-48.0%0.456%
2/18/2026Boothbay Fund Management LLC155,741$254K0.0%-68.0%0.219%
2/17/2026ADAR1 Capital Management LLC4,285,000$6.99M0.5%+33,256.7%6.017%
2/17/2026Schonfeld Strategic Advisors LLC192,496$314K0.0%-78.2%0.270%
2/17/2026Ally Bridge Group NY LLC1,785,000$2.91M3.0%N/A2.507%
2/17/2026RA Capital Management L.P.10,714,000$17.46M0.2%N/A15.046%
2/17/2026Adage Capital Partners GP L.L.C.3,492,000$5.69M0.0%+158.7%4.904%
2/17/2026Graham Capital Management L.P.127,459$208K0.0%N/A0.179%
2/16/2026Squarepoint Ops LLC39,034$64K0.0%-66.0%0.055%
2/16/2026OMERS ADMINISTRATION Corp125,300$204K0.0%N/A0.176%
2/16/2026Eventide Asset Management LLC4,285,000$6.99M0.1%N/A6.017%
2/13/2026Marshall Wace LLP1,271,487$2.07M0.0%+62.3%1.786%
2/13/2026Walleye Capital LLC530,020$864K0.0%-11.2%0.744%
2/13/2026Affinity Asset Advisors LLC7,150,000$11.65M0.7%+169.8%10.041%
2/13/2026AWM Investment Company Inc.899,200$1.47M0.1%N/A1.263%
2/13/2026State Street Corp276,533$451K0.0%+21.8%0.388%
2/13/2026Wells Fargo & Company MN720,848$1.18M0.0%-1.4%1.012%
2/12/2026Jane Street Group LLC883,867$1.44M0.0%+270.7%1.241%
2/12/2026Renaissance Technologies LLC1,484,478$2.42M0.0%-26.4%2.085%
2/12/2026Federated Hermes Inc.3,571,000$5.31M0.0%N/A5.015%
They proved it worked in '76. Then buried it. (Ad)

In 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the project. Unocal and Texaco did the same. All three buried the results because it threatened their core business. Now one company has spent sixty years developing what Big Oil refused to touch. Google locked in a 15-year contract, Bill Gates wrote a $100 million check, and on August 18th the government hands it a competitive edge no other energy source receives.tc pixel

Discover the company that spent 60 years proving this technology works
2/11/2026LPL Financial LLC30,000$49K0.0%+150.0%0.042%
2/10/2026Goldman Sachs Group Inc.170,457$278K0.0%+497.7%0.239%
2/9/2026Geode Capital Management LLC672,004$1.10M0.0%+3.7%0.944%
2/2/2026Total Clarity Wealth Management Inc.28,600$47K0.0%N/A0.040%
1/12/2026Benin Management CORP19,000$31K0.0%N/A0.027%
1/9/2026 Assenagon Asset Management S.A.618,019$1.01M0.0%-33.2%0.868%
11/17/2025Qube Research & Technologies Ltd25,277$33K0.0%-65.3%0.035%
11/17/2025Parkman Healthcare Partners LLC202,978$264K0.0%N/A0.285%
11/17/2025Millennium Management LLC986,293$1.28M0.0%-6.3%1.385%
11/17/2025Integrated Wealth Concepts LLC52,900$69K0.0%N/A0.074%
11/17/2025Bank of America Corp DE362,707$472K0.0%+2,333.0%0.509%
11/17/2025Boothbay Fund Management LLC486,877$633K0.0%N/A0.684%
11/14/2025Schonfeld Strategic Advisors LLC883,154$1.15M0.0%N/A1.240%
11/14/2025Two Sigma Investments LP341,134$443K0.0%N/A0.480%
11/14/2025Squarepoint Ops LLC114,923$149K0.0%-48.0%0.162%
11/13/2025Kennedy Capital Management LLC1,106,638$1.44M0.0%-26.3%1.556%
11/13/2025Private Advisor Group LLC25,600$33K0.0%N/A0.036%
11/10/2025Persistent Asset Partners Ltd46,040$60K0.0%N/A0.065%
11/7/2025GSA Capital Partners LLP265,993$346K0.0%-64.2%0.374%
11/7/2025Vanguard Group Inc.2,820,813$3.67M0.0%+7.0%3.967%
11/4/2025TLS Advisors LLC18,858$26K0.1%-97.2%0.027%
10/17/2025Apollon Wealth Management LLC27,500$36K0.0%N/A0.039%
10/7/2025 Assenagon Asset Management S.A.924,576$1.20M0.0%+112.2%1.300%
8/15/2025Rosalind Advisors Inc.500,000$165K0.1%N/A0.703%
8/15/2025Rubric Capital Management LP478,533$158K0.0%-91.0%0.673%
8/14/2025Jane Street Group LLC142,597$47K0.0%N/A0.201%
8/14/2025Velan Capital Investment Management LP160,000$53K0.1%+64.9%0.225%
8/13/2025Marshall Wace LLP164,721$54K0.0%N/A0.232%
8/13/2025Kennedy Capital Management LLC1,502,329$496K0.0%-13.3%2.113%
8/8/2025Geode Capital Management LLC643,335$212K0.0%-51.7%0.905%
8/1/2025Y Intercept Hong Kong Ltd160,306$53K0.0%N/A0.225%
7/11/2025 Assenagon Asset Management S.A.435,620$144K0.0%-22.3%0.613%
6/27/2025Goldman Sachs Group Inc.104,435$33K0.0%-47.3%0.147%
5/21/2025Acadian Asset Management LLC2,088,046$650K0.0%+12.8%2.936%
5/16/2025Goldman Sachs Group Inc.104,435$33K0.0%-47.3%0.147%
5/16/2025Jacobs Levy Equity Management Inc.200,593$63K0.0%-31.2%0.282%
5/16/2025Adage Capital Partners GP L.L.C.1,150,000$359K0.0%+15.0%1.617%
5/14/2025Affinity Asset Advisors LLC667,516$208K0.0%N/A0.939%
5/12/2025Nuveen LLC119,113$37K0.0%N/A0.168%
5/8/2025XTX Topco Ltd93,154$29K0.0%N/A0.131%
4/15/2025Assenagon Asset Management S.A.560,830$175K0.0%+699.9%0.789%
2/17/2025Velan Capital Investment Management LP70,000$65K0.1%N/A0.099%
2/17/2025Madison Avenue Partners LP3,722,627$3.48M0.4%-9.6%5.242%
2/17/2025OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC943,416$881K0.1%+50.2%1.329%
2/17/2025Jacobs Levy Equity Management Inc.291,701$272K0.0%N/A0.411%
2/17/2025Bridgeway Capital Management LLC229,115$214K0.0%-26.0%0.323%
2/17/2025Bank of America Corp DE56,733$53K0.0%+49.7%0.080%
2/17/2025BNP Paribas Financial Markets104,712$98K0.0%-52.5%0.147%
2/14/2025Adage Capital Partners GP L.L.C.1,000,000$934K0.0%N/A1.408%
2/13/2025Kennedy Capital Management LLC1,545,387$1.44M0.0%+1.1%2.176%
Read now. Do not delete. You’ve been warned. (Ad)

Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” Porter Stansberry exposes how the convergence of three immense forces is about to rewrite everything about the American way of life: how you work, save, invest… it’s all about to change.tc pixel

Don’t be left behind. Click here now.
2/13/2025Renaissance Technologies LLC107,700$101K0.0%+142.0%0.152%
2/13/2025ADAR1 Capital Management LLC130,532$122K0.0%+245.8%0.184%
2/12/2025TLS Advisors LLC680,967$636K1.5%-11.7%0.959%
2/12/2025Takeda Pharmaceutical Co. Ltd.7,531,996$7.01M26.4%N/A10.607%
2/12/2025JPMorgan Chase & Co.1,418,306$1.32M0.0%-3.1%1.997%
2/10/2025Monimus Capital Management LP138,266$129K0.1%N/A0.195%
1/30/2025Rhumbline Advisers84,078$79K0.0%+22.3%0.118%
1/17/2025SG Americas Securities LLC37,636$35K0.0%+83.9%0.053%
1/14/2025Assenagon Asset Management S.A.70,114$65K0.0%-18.7%0.099%
11/19/2024Barclays PLC84,175$98K0.0%+311.2%0.119%


OVID Institutional Ownership - Frequently Asked Questions

During the previous two years, 72 institutional investors and hedge funds held shares of Ovid Therapeutics. The most heavily invested institutionals were Janus Henderson Group PLC ($23.73M), Affinity Asset Advisors LLC ($23.61M), RA Capital Management L.P. ($17.46M), ADAR1 Capital Management LLC ($10.09M), Takeda Pharmaceutical Co. Ltd. ($7.01M), Eventide Asset Management LLC ($6.99M), and Ally Bridge Group NY LLC ($6.26M).Learn more on Ovid Therapeutics' institutional investors.

72.24% of Ovid Therapeutics' stock is owned by institutional investors. Learn more on OVID's institutional investor holdings.

Of the 59 institutional investors that purchased Ovid Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Janus Henderson Group PLC ($10.71M), RA Capital Management L.P. ($10.71M), ADAR1 Capital Management LLC ($8.90M), Affinity Asset Advisors LLC ($8.65M), Takeda Pharmaceutical Co. Ltd. ($7.53M), Eventide Asset Management LLC ($4.29M), and Federated Hermes Inc. ($3.57M).

Institutional investors have bought a total of 58,762,818 shares in the last 24 months. This purchase volume represents approximately $102.92M in transactions.

Of the 18 institutional investors that sold Ovid Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Rubric Capital Management LP ($4.84M), Renaissance Technologies LLC ($913.72K), Assenagon Asset Management S.A. ($907.03K), Ikarian Capital LLC ($848.02K), Schonfeld Strategic Advisors LLC ($690.66K), Geode Capital Management LLC ($687.66K), and TLS Advisors LLC ($662.11K).

Institutional investors have sold a total of 11,771,838 shares in the last 24 months. This volume of shares sold represents approximately $11.87M in transactions.


Related Companies

This page (NASDAQ:OVID) was last updated on 7/14/2026 by MarketBeat.com Staff.
From Our Partners
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Trump’s $250 Bill – See Immediately
Former Goldman Sachs VP Dr. David Eifrig is warning that July 28 could trigger the biggest wealth reset in mod...
Stansberry Research | Sponsoredtc pixel
When I found Rolls-Royce under $2, most people thought I was crazy
In 2022, Karim Rahemtulla recommended Rolls-Royce when it traded under $2. The stock climbed more than 1,100% ...
Monument Traders Alliance | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
Your money is changing
Porter Stansberry - who warned readers about Fannie Mae in 2006, called gold in 2008, and predicted COVID-era ...
Porter & Company | Sponsoredtc pixel
The $5 company SpaceX can’t survive without
The investors who got rich on AI didn't all buy Nvidia. Some bought ASML, the company that makes the machines ...
Traders Agency | Sponsoredtc pixel
Trump Set to Unleash 219-Year-Old “Super Weapon” on U.S. Soil
Four-time U.S. Presidential advisor Jim Rickards is warning of a political move he calls 'The Trump Supremacy'...
Paradigm Press | Sponsoredtc pixel
60 years. Zero competitors.
One company has spent 60 years developing an energy source the International Energy Agency estimates at 140 ti...
Behind the Markets | Sponsoredtc pixel